Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Black Women Less Likely Than White Women To Receive Follow-Up Treatments After Breast Cancer Surgery, Study Finds
http://www.medicalnewstoday.com/articles/120454.php
Black women who undergo a lumpectomy surgery to treat early-stage breast cancer are less likely than their white counterparts to receive the recommended follow-up radiation therapy treatments, according to study released on Wednesday, <a href="http://www.
OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference
http://www.medicalnewstoday.com/articles/120422.php
OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, <i>Biochemical and Biophysical Research Communications</i>, Volume 370, Issue 1, Pages 109-112.
Change In HER2 Status After Treatment With Herceptin Discovered By M. D. Anderson Study
http://www.medicalnewstoday.com/articles/120379.php
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.
Blacks Less Likely Than Whites To Receive Standard Of Care In Radiation Therapy For Breast Cancer
http://www.medicalnewstoday.com/articles/120377.php
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M.
Agendia Launches TargetPrint(R) For Breast Cancer Patients
http://www.medicalnewstoday.com/articles/120337.php
Agendia, a world leader in molecular cancer diagnostics, announced the launch of TargetPrint(R), a new diagnostic test that allows physicians to quantitatively determine the gene expression levels of the estrogen receptor (ER), progesterone receptor (PR) and Human Epidermal growth factor Receptor 2 (HER2) in breast cancer tumor biopsies.
----------------------------------------------
** CANCER / ONCOLOGY News **
Scientists Map Complete Genetic Blueprint Of Deadly Cancers
http://www.medicalnewstoday.com/articles/120565.php
In what has been heralded as a significant breakthrough in the fight against two of the world's deadliest cancers, US scientists have mapped complete genetic blueprints comprising more than 20,000 genes in 24 pancreatic cancers and 22 brain cancers, including not only individual gene mutations but also their interlinked pathways which sustain tumour development and growth.
Goshen Center For Cancer Care Doctor Named Naturopathic Physician Of The Year
http://www.medicalnewstoday.com/articles/120448.php
Goshen Center for Cancer Care's Director of Integrated Care, Marcia Prenguber, ND, FABNO, has been chosen as the 2008 Naturopathic Physician of the Year by the American Association of Naturopathic Physicians.
Discovery Challenges Fundamental Tenet Of Cancer Biology
http://www.medicalnewstoday.com/articles/120434.php
Yale researchers have identified an unusual molecular process in normal tissues that causes RNA molecules produced from separate genes to be clipped and stitched together. The discovery that these rearranged products exist in normal as well as cancerous cells potentially complicates the diagnosis of some cancers and raises the possibility that anti-cancer drugs like Gleevec could have predictable side effects.
OncoMune Publishes Positive Results Of OCM-8054 - Breast Cancer Dependency On BORIS Unequivocally Demonstrated By RNA Interference
http://www.medicalnewstoday.com/articles/120422.php
OncoMune LLC, a biotechnology company focused on developing targeted cancer therapeutics, announced the publication of its preclinical OCM-8054 data. The publication entitled, "Selective apoptosis of breast cancer cells by siRNA targeting of BORIS," appeared in the May 23rd 2008 issue of the scientific journal, <i>Biochemical and Biophysical Research Communications</i>, Volume 370, Issue 1, Pages 109-112.
Bladder Tumor Markers: From Hematuria To Molecular Diagnostics - Where Do We Stand?
http://www.medicalnewstoday.com/articles/120398.php
UroToday.com - Bladder cancer is an extremely lethal disease occurring in a large number of patients each year. Most evaluations that result in the diagnosis of bladder cancer are initiated with the finding of either gross or microscopic hematuria.
Scientists 'Stand Up To Cancer' With Latest Research
http://www.medicalnewstoday.com/articles/120388.php
As the Stand Up To Cancer campaign -- being put forth by television's "Big 3" networks -- is opening the nation's eyes to the need and the benefit of cancer research dollars, The Cancer Institute of New Jersey (CINJ) is highlighting some of its groundbreaking studies being conducted by internationally recognized clinical investigators.
September 13th Is National Childhood Cancer Awareness Day
http://www.medicalnewstoday.com/articles/120382.php
A pediatric bone cancer survivor who now is studying to become a pediatric hematologist/oncologist…a childhood leukemia survivor who has walked a mile in the shoes of the young cancer patients she now treats.
Azaya Therapeutics Licenses Promising Treatment For Head And Neck Cancers
http://www.medicalnewstoday.com/articles/120361.php
Azaya Therapeutics, Inc., announced that it has signed a licensing agreement to further develop a breakthrough technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy.
Evident™ Microwave Ablation System Offers Surgical Oncologists And Interventional Radiologists Fast, Efficient Tool To Ablate Soft Tissue
http://www.medicalnewstoday.com/articles/120346.php
Covidien (NYSE: COV, BSX: COV), a world leader in advanced energy-based surgical systems, today announced the global release of the Evident™ microwave ablation system. Physicians now have a powerful new tool with industry-leading technology to ablate soft tissue.
Medarex Announces Presentations At The 33rd Congress Of The European Society For Medical Oncology
http://www.medicalnewstoday.com/articles/120335.php
Medarex, Inc. (Nasdaq: MEDX) announced that nine clinical abstracts for ipilimumab, an investigational anti-CTLA-4 antibody, in melanoma are scheduled to be the subject of presentations at the 33rd Congress of the European Society for Medical Oncology (ESMO) being held September 12-16, 2008 in Stockholm.
Blood 'Fingerprints' For Cancer
http://www.medicalnewstoday.com/articles/120332.php
Serum microRNAs (miRNAs) can serve as biomarkers for the detection of diseases including cancer and diabetes, according to research published online this week in <i>Cell Research</i>. The findings pave the way for a revolutionary non-invasive diagnostic tool.
Nanoscale Droplets With Cancer-Fighting Implications Produced By Scientists
http://www.medicalnewstoday.com/articles/120331.php
UCLA scientists have succeeded in making unique nanoscale droplets that are much smaller than a human cell and can potentially be used to deliver pharmaceuticals. "What we found that was unexpected was within each oil droplet there was also a water droplet - a double emulsion," said Timothy Deming, professor and chair of the UCLA Department of Bioengineering and a member of both the California NanoSystems Institute (CNSI) at UCLA and UCLA's Jonsson Cancer Center.
News From CA: Cancer Quality Alliance, Blueprint For A Better Cancer Care System
http://www.medicalnewstoday.com/articles/120316.php
<b>Cancer Quality Alliance: Blueprint for a Better Cancer Care System</b>In this report, the Cancer Quality Alliance (CQA), a national alliance advocating for improvements in the quality of cancer care in America, presents a set of 5 case studies that depict a vision of quality cancer care and a "Blueprint" for actions to realize this vision.
Few Parents Fear Cervical Cancer Jab Causes Promiscuity In Teens
http://www.medicalnewstoday.com/articles/120303.php
Few parents worry that vaccinating their daughters against human papillomavirus (HPV) and cervical cancer would cause promiscuity. This is the finding of Dr Noel Brewer and colleagues from the University of North Carolina, USA and the Centers for Disease Control who will present their findings on Tuesday 9 September 2008 at the British Psychological Society's Division of Health Psychology's Annual Conference being held at the University of Bath.
International Team Reveals First Prognosticator Of Survival In Aggressive Cancer
http://www.medicalnewstoday.com/articles/120286.php
The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS), according to an international collaboration of researchers, including scientists at the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA, the Department of Human Pathology and Oncology, University of Siena and the Center of Oncological Research of Mercogliano (CROM) in Avellino, Italy.
Cytopia Commences Second Phase II Study In Brain Cancer
http://www.medicalnewstoday.com/articles/120265.php
Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
Scientists Who Linked HPV With Cervical Cancer Win 20th Annual Warren Alpert Foundation Prize
http://www.medicalnewstoday.com/articles/120362.php
Two scientists who discovered that specific types of human papillomavirus, or HPV, cause cancer of the cervix were announced as winners of the 20th annual Warren Alpert Foundation Scientific Prize.
Few Parents Fear Cervical Cancer Jab Causes Promiscuity In Teens
http://www.medicalnewstoday.com/articles/120303.php
Few parents worry that vaccinating their daughters against human papillomavirus (HPV) and cervical cancer would cause promiscuity. This is the finding of Dr Noel Brewer and colleagues from the University of North Carolina, USA and the Centers for Disease Control who will present their findings on Tuesday 9 September 2008 at the British Psychological Society's Division of Health Psychology's Annual Conference being held at the University of Bath.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
African Americans Have Unique Lung Cancer Risks From Chronic Obstructive Pulmonary Disease
http://www.medicalnewstoday.com/articles/120235.php
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD), according to a report published in the September issue of <a href="http://cancerpreventionresearch.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
HIV And Prostate Cancer: A Systematic Review Of The Literature
http://www.medicalnewstoday.com/articles/120406.php
UroToday.com - In the online edition of Prostate Cancer Prostatic Diseases, Dr. Jonathan Silberstein and his colleagues presented a systematic review of HIV and prostate cancer (CaP). The message that may be underappreciated by the urology community is the excellent longevity of HIV patients, which clearly impacts their potential for diagnosis and management of CaP.
Testosterone Administration To Men With Testosterone Deficiency Syndrome After External Beam Radiotherapy For Localized Prostate Cancer
http://www.medicalnewstoday.com/articles/120399.php
UroToday.com - Dr. Alvaro Morales and associates from the Centre for Applied Urological Research, reported on the first study on testosterone deficiency syndrome (TDS) in men treated with radiotherapy for prostate cancer.
Report On Bisphenol A Finalized By NTP
http://www.medicalnewstoday.com/articles/120291.php
Current human exposure to bisphenol A (BPA), a chemical used in many polycarbonate plastics and epoxy resins, is of "some concern" for effects on development of the prostate gland and brain and for behavioral effects in fetuses, infants and children, according to a final report released today by the National Toxicology Program (NTP).
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment